Puissance Capital Management LP

CIK 1658437 · last filed 2023-10-16

Puissance Capital Management LP is a corporate insider who has filed 5 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing shows the insider sold $447.1K of BLPH on Oct 16, 2023. Across all open-market trades the lifetime net is −$22.1M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

5

Lifetime Open-Market Net

-$22.08M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Bellerophon Therapeutics, Inc. (BLPH) Delisted 10%+ Owner 0 $0.01 $0 -$22.08M 4 2023-10-16
ChronoScale Corp (EKSO) Delisted 10%+ Owner 91,438 $11.80 $1.08M $0 1 2020-01-21

Recent Filings

5 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-10-16 Bellerophon Therapeutics, Inc. (BLPH) Delisted Sell (S) −4,307,364 -$447.1K EDGAR
2023-06-07 Bellerophon Therapeutics, Inc. (BLPH) Delisted Sell (S) −537,684 -$446.3K EDGAR
2023-05-19 Bellerophon Therapeutics, Inc. (BLPH) Delisted Sell (S) −2,240,000 -$21.19M EDGAR
2020-04-20 Bellerophon Therapeutics, Inc. (BLPH) Delisted Other (J) −2,766,250 $0 EDGAR
2020-01-21 ChronoScale Corp (EKSO) Delisted Grant (A) +97,225 $43.8K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.